Equity Profile
Pre-Earnings Brief
Roivant Sciences Ltd.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
Liquidia Corporation is a healthcare company focused on developing innovative treatments for patients with serious diseases. Operating in the pharmaceuticals sector, it aims to improve patient outcomes through its unique drug delivery technologies.
Earnings Per Share (EPS)
EPS is a key indicator of the company's profitability and growth potential, which investors closely monitor.
Revenue Growth
Revenue growth reflects the company's ability to expand its market presence and drive sales, crucial for long-term sustainability.
Wall Street expectations, options signals, track record, and call prep available with Pro.
$6.0M
Net selling
$404,401.77
Net selling
$525,362.04
Net selling
Recent Transactions
Apr 9, 2026 · @ $40.24
133,789 sh
$5.4M
Apr 15, 2026 · @ $40.14
86,971 sh
$3.5M
Apr 15, 2026 · @ $40.14
43,375 sh
$1.7M
Apr 13, 2026 · @ $38.37
32,744 sh
$1.3M
Apr 16, 2026 · @ $40.31
25,000 sh
$1.0M
Open-market trades only (Form 4 codes P/S). Awards, exercises, and tax-withholding excluded as routine compensation noise.